InsidersTradesSigma
Browse the complete record of transactions filed by BIZZARI JEAN-PIERRE, Director. Officer active across 1 companies, notably Halozyme Therapeutics, INC.. In total, 5 disclosures have been published. Total volume traded: €2.4m. The latest transaction was filed on 5 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Jean-Pierre Bizzari is a Director at Halozyme Therapeutics, Inc. He brings valuable expertise in corporate governance and business strategy. His role involves overseeing the company's operations and contributing to strategic decision-making. With a strong background in the biopharmaceutical sector, he is involved in developing innovative solutions to improve patient health.